CRSP Q2 EPS Estimate Reduced by Brookline Capital Management
CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) – Analysts at Brookline Capital Management cut their Q2 2025 earnings estimates for shares of CRISPR Therapeutics in a research report issued on Tuesday, May 6th. Brookline Capital Management analyst L. Cann now expects that the company will post earnings of ($1.23) per share for the quarter, down […]
More Stories
What to Know About Alligator Alcatraz: The Deportation Center Surrounded by 30,000 Alligators
By T.J. Muscaro Deep in the Florida Everglades, the latest illegal immigration detention and deportation facility opened for business on...
Rain, Thunderstorms Expected to Dampen Fourth of July for Parts of Gulf
By T.J. Muscaro TAMPA BAY, Fla.—People looking to celebrate the Fourth of July on the Gulf along Florida’s Peninsula should...
Universal Basic Income Is Coming: Are We Ready for a Jobless Future
By Stephen Zogopoulos, USNN World News In a world racing toward automation, Elon Musk—a man who’s rarely wrong when it...
Is Temu Legit? Honest Reviews, Pros, Cons & Alternatives
In this era of fast fashion, Temu is a top contender in the American market. Giving tough competition to marketplace...
Dan Da Dan Season 2 Confirmed: Release Date & What to Expect
Anime has become a global favorite, crossing borders and entertaining millions. Dan Da Dan, an adaptation of Manga, has become...
Mirae Asset Global Investments Co. Ltd. Has $3.85 Million Stock Position in Nucor Corporation (NYSE:NUE)
Mirae Asset Global Investments Co. Ltd. increased its holdings in shares of Nucor Corporation (NYSE:NUE – Free Report) by 17.8%...